Literature DB >> 12946648

Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases.

Hasan El-Hassan1, Khurshid Anwar, Patricia Macanas-Pirard, Mark Crabtree, Sek C Chow, Victoria L Johnson, Pauline C Lee, Richard H Hinton, Shirley C Price, George E N Kass.   

Abstract

The role of apoptosis in acetaminophen (AAP)-induced hepatic injury was investigated. Six hours after AAP administration to BALB/c mice, a significant loss of hepatic mitochondrial cytochrome c was observed that was similar in extent to the loss observed after in vivo activation of CD95 by antibody treatment. AAP-induced loss of mitochondrial cytochrome c coincided with the appearance in the cytosol of a fragment corresponding to truncated Bid (tBid). At the same time, tBid became detectable in the mitochondrial fraction, and concomitantly, Bax was found translocated to mitochondria. However, AAP failed to activate the execution caspases 3 and 7 as evidenced by a lack of procaspase processing and the absence of an increase in caspase-3-like activity. In contrast, the administration of the pan-inhibitor of caspases, benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone (but not its analogue benzyloxycarbonyl-Phe-Ala-fluoromethylketone) prevented the development of liver injury by AAP and the appearance of apoptotic parenchymal cells. This correlated with the inhibition of the processing of Bid to tBid. The caspase inhibitor failed to prevent both the redistribution of Bax to the mitochondria and the loss of cytochrome c. In conclusion, apoptosis is an important causal event in the initiation of the hepatic injury inflicted by AAP. However, as suggested by the lack of activation of the main execution caspases, apoptosis is not properly executed and degenerates into necrosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946648     DOI: 10.1016/s0041-008x(03)00240-0

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  43 in total

1.  Novel protective mechanisms for S-adenosyl-L-methionine against acetaminophen hepatotoxicity: improvement of key antioxidant enzymatic function.

Authors:  James Michael Brown; John G Ball; Michael Scott Wright; Stephanie Van Meter; Monica A Valentovic
Journal:  Toxicol Lett       Date:  2012-06-05       Impact factor: 4.372

2.  ORY supplementation mitigates acetaminophen-induced acute liver failure in male mice: role of oxidative stress and apoptotic markers.

Authors:  Marcelo Gomes de Gomes; Lucian Del Fabbro; André Rossito Goes; Leandro Cattelan Souza; Silvana Peterini Boeira; Cristiano Ricardo Jesse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-29       Impact factor: 3.000

3.  Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling.

Authors:  Aiming Liu; Naoki Tanaka; Lu Sun; Bin Guo; Jung-Hwan Kim; Kristopher W Krausz; Zhongze Fang; Changtao Jiang; Julin Yang; Frank J Gonzalez
Journal:  Chem Biol Interact       Date:  2014-09-27       Impact factor: 5.192

4.  Hepatoprotective effects of lactic acid-fermented garlic extract against acetaminophen-induced acute liver injury in rats.

Authors:  Hee Seop Lee; Won Chul Lim; Sung Jin Lee; Seung Hyun Lee; Heui Jong Yu; Jin Hyup Lee; Hong Yon Cho
Journal:  Food Sci Biotechnol       Date:  2016-06-30       Impact factor: 2.391

5.  Acetaminophen Hepatotoxicity.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Semin Liver Dis       Date:  2019-03-08       Impact factor: 6.115

6.  The effect of aging on mitochondrial and cytosolic hepatic intrinsic death pathway and apoptosis associated proteins in Fischer 344 rats.

Authors:  John Mach; Aniko Huizer-Pajkos; Alice Kane; Brett Jones; Catriona McKenzie; Sarah J Mitchell; Rafael de Cabo; Victoria C Cogger; David G Le Couteur; Sarah N Hilmer
Journal:  Exp Gerontol       Date:  2015-04-22       Impact factor: 4.032

7.  Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity.

Authors:  Benjamin L Woolbright; Anup Ramachandran; Mitchell R McGill; Hui-min Yan; Mary Lynn Bajt; Matthew R Sharpe; John J Lemasters; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2012-09-25       Impact factor: 4.080

8.  Development of an accurate index for predicting outcomes of patients with acute liver failure.

Authors:  Anna Rutherford; Lindsay Y King; Linda S Hynan; Chetan Vedvyas; Wenyu Lin; William M Lee; Raymond T Chung
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

Review 9.  Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products.

Authors:  Hartmut Jaeschke; C David Williams; Mitchell R McGill; Yuchao Xie; Anup Ramachandran
Journal:  Food Chem Toxicol       Date:  2013-01-22       Impact factor: 6.023

Review 10.  Immune cell-mediated liver injury.

Authors:  Nadia Corazza; Anastasia Badmann; Christoph Lauer
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.